HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +5.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 502.79K | $49.11M | n/a | −1 |
| Q2 2026 | 131 | -1 | 91.15M | $6.60B | +6 | −8 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | n/a | n/a |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | n/a | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | n/a | −1 |
| Q2 2024 | 14 | n/a | 8.14M | $426.06M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 13.20M | n/a | $686.67M | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 2 | The Vanguard Group ✦ (被动) | 12.25M | n/a | $637.02M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 5.94M | -1.9% | $308.74M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | Arrowstreet Capital ✦ | 2.54M | +127.8% | $132.19M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.43M | -23.2% | $126.56M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | T. Rowe Price ✦ | 1.03M | -13.0% | $53.70M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 1.02M | +64.4% | $53.00M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Norges Bank ✦ (被动) | 865.57K | +3.8% | $45.03M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 9 | Capital World Investors ✦ | 782.00K | +4.5% | $40.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Millennium Management ✦ | 690.47K | +1534.9% | $35.92M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Two Sigma Investments ✦ | 439.84K | -31.9% | $22.88M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 389.13K | -16.1% | $20.24M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 381.75K | -8.6% | $19.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 378.80K | +1043.1% | $19.71M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 15 | Renaissance Technologies ✦ | 338.61K | +182.2% | $17.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 311.40K | +292.1% | $16.20M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 17 | Wellington Management ✦ | 103.67K | +94.5% | $5.39M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 18 | Fidelity (FMR) ✦ | 84.56K | n/a | $4.40M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 19 | Gotham Asset Management ✦ | 68.05K | +109.2% | $3.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 630 持有人, 119.44M 股份, $7.40B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 200 股 · $22,102
Officer, Director · 11.90K 股 · $1.31M
Officer, Director · 3.09K 股 · $336,526
Officer, Director · 4.81K 股 · $520,341
Officer, Director · 8.60K 股 · $954,867
Officer, Director · 200 股 · $22,739
Officer, Director · 900 股 · $101,502
Officer, Director · 10.30K 股 · $1.15M
Officer, Director · 1.78K 股 · $197,245
Officer, Director · 9.92K 股 · $1.09M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论